EUCTR2007-003478-25-IT进行中（未招募）不适用
?The effect of acute and chronic administration of the CCK1 receptor antagonist Dexloxiglumide (CR2017) on 24-h pH metry, LES motor and symptoms? pattern, in patients with gastroesophageal reflux disease (GERD). A randomized, double-blind, placebo controlled study? - ND
ROTTAPHARM / ROTTA RESEARCH LABORATORIUM0 个研究点开始时间: 2009年3月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- males or female - age >=18 and <=70 - patients with the symptoms of gastroesaphageal reflux disease (GERD) - heartburn, gastric burning sensation and regurgitation - according to the following: presence of all the 3 symptoms, regardless of intensity or duration, presence of at least one of the 3 symptoms, with intensity at least moderate or duration at least between 15 and 30 minutes daily - signed informed consent - use of contraceptive methods for women of child-bearing potential
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- hiatal hernia - abdominal surgery - pregnant or breast-feeding females - significant diseases - use of prohibited medication (among which, H2 blockers and antiacids)
研究者
相似试验
进行中（未招募）
1 期
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849EUCTR2011-000579-15-GBInstitut de Recherches Internationales Servier36
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849EUCTR2011-000579-15-DEInstitut de Recherches Internationales Servier
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1EUCTR2011-000579-15-FIInstitut de Recherches Internationales Servier
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1EUCTR2011-000579-15-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER36
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849EUCTR2011-000579-15-HUInstitut de Recherches Internationales Servier36